Douglas Pharmaceuticals announces positive top-line results from Phase 2 trial of R-107 in subjects with Treatment Resistant Depression - Yahoo Finance

Submitted by Anonymous (not verified) on Thu, 12/16/2021 - 14:00

Douglas Pharmaceuticals announces positive top-line results from Phase 2 trial of R-107 in subjects with Treatment Resistant Depression  Yahoo Finance